RecruitingNCT07593547

Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections

Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections: A Multicentre Study Using Target Trial Emulation

Sponsor

Instituto de Investigación Sanitaria Gregorio Marañón

Enrollment

790 participants

Start Date

Mar 6, 2026

Study Type

OBSERVATIONAL

Conditions

bloodstream infection Pneumonia, Bacterial S Maltophilia Infections

Summary

The goal of this multicentre observational study is to analyse the treatment strategies and the outcomes for patients with S. maltophilia infections using target trial emulation methodology. The main question it aims to answer is: • Does combined therapy achieve better results than monotherapy in treating S. maltophilia infections? Researchers will compare groups receiving monotherapy and combined therapy to see if there are differences in all-cause 30-day mortality.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with pneumonia, bacterial, s maltophilia infections, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.